3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Melanoma
4
Endometrial Neoplasms
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Neoplasm Metastasis
3
Rectal Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
1
Multiple Myeloma
1
Mouth Neoplasms
1
Laryngeal Diseases
1
Hodgkin Disease
1
Hepatoblastoma
1
Glioblastoma
1
Interventions
dostarlimab
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
×
dostarlimab
×
Clear all
NCT06879717
2026-01-16
PULMO-01
iOnctura
Phase 1/2
Active not recruiting
45 enrolled